1. Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results. Issue 7 (25th November 2021) Authors: Agarwal, Rajiv; Anker, Stefan D; Filippatos, Gerasimos; Pitt, Bertram; Rossing, Peter; Ruilope, Luis M; Boletis, John; Toto, Robert; Umpierrez, Guillermo E; Wanner, Christoph; Wada, Takashi; Scott, Charlie; Joseph, Amer; Ogbaa, Ike; Roberts, Luke; Scheerer, Markus F; Bakris, George L Journal: Nephrology dialysis transplantation Issue: Volume 37:Issue 7(2022) Page Start: 1261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of efpeglenatide versus liraglutide on gastric emptying, glucose metabolism and beta-cell function in people with type 2 diabetes: an exploratory, randomized phase Ib study. Issue 1 (25th June 2021) Authors: Hompesch, Marcus; Kang, Jahoon; Han, OakPil; Trautmann, Michael E; Sorli, Christopher H; Ogbaa, Ike; Stewart, John; Morrow, Linda Journal: BMJ open diabetes research and care Issue: Volume 9:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Study Design and Rationale of a Dose‐Ranging Trial of LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy. Issue 7 (29th April 2013) Authors: Lapuerta, Pablo; Rosenstock, Julio; Zambrowicz, Brian; Powell, David R.; Ogbaa, Ike; Freiman, Joel; Cefalu, William T.; Banks, Phillip; Frazier, Kenny; Kelly, Mike; Sands, Arthur Journal: Clinical cardiology Issue: Volume 36:Issue 7(2013:Jul.) Page Start: 367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗